Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 35,028 | reported | 19 Mar 2026 | tx 52+533,558−153,221 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,174 | 67.00 USD | |
| 17 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,029 | 69.42 USD | |
| 18 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,071 | 68.71 USD | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 23,909 | — | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,176 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,248 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,463 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,022 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 27,310 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 17,161 | 0.00 USD | deriv |
| 02 Jan 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 835 | 81.90 USD | |
| 02 Jan 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 893 | 82.93 USD | |
| 02 Jan 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 8,122 | 80.71 USD | |
| 02 Jan 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 5,715 | 80.09 USD | |
| 16 Dec 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 7,397 | 80.10 USD | |
| 18 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2,315 | 46.29 USD | |
| 19 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2,259 | 47.40 USD | |
| 20 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 2,137 | 50.11 USD | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 18,885 | — | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,462 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,175 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7,248 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30,628 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20,089 | 0.00 USD | deriv |
| 18 Mar 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4,314 | 30.60 USD |